secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOLARGO, INC. (BLGO)
CIK:        0000880242
Form:       8-K
Filed at:   2023-03-27T23:59:59+00:00
Accession:  0001437749-23-007938
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioLargo extends CFO Charles Dargan's engagement through Jan 2024; grants option for 300,000 shares
--------------------------------------------------------------------------------

- CFO Charles K. Dargan II's engagement extended one year to January 31, 2024.
- Compensation: option to purchase 300,000 shares of common stock at $0.20/share.
- Option vests monthly (25,000 shares/month) starting March 21, 2023; expires in 10 years.
- No cash compensation; CFO eligible for business expense reimbursement (historically not requested).
- Prior extension expired January 31, 2023; agreement may be terminated on 30 days' notice.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/880242/000143774923007938/0001437749-23-007938-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/880242/000143774923007938/blgo20230322_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-007938

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer